- Home
- ELF vs TNGX Comparison
ELF vs TNGX Comparison
Compare ELF & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELF | TNGX |
|---|---|---|
| Founded | 2004 | 2014 |
| Country | United States | United States |
| Employees | 633 | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.7B |
| IPO Year | 2016 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ELF | TNGX |
|---|---|---|
| Price | $55.68 | $23.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 17 | 10 |
| Target Price | ★ $111.88 | $21.78 |
| AVG Volume (30 Days) | 2.3M | ★ 2.7M |
| Earning Date | 05-27-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 26.89 |
| EPS | ★ 1.28 | N/A |
| Revenue | ★ $1,313,517,000.00 | $62,384,000.00 |
| Revenue This Year | $23.87 | N/A |
| Revenue Next Year | $17.15 | N/A |
| P/E Ratio | $42.89 | ★ N/A |
| Revenue Growth | N/A | ★ 48.29 |
| 52 Week Low | $54.70 | $1.91 |
| 52 Week High | $150.99 | $28.41 |
Technical Indicators
Market Signals| Indicator | ELF | TNGX |
|---|---|---|
| Relative Strength Index (RSI) | 34.01 | 52.76 |
| Support Level | N/A | $20.76 |
| Resistance Level | $96.30 | $28.41 |
| Average True Range (ATR) | 2.78 | 1.66 |
| MACD | -0.49 | -0.36 |
| Stochastic Oscillator | 12.01 | 42.18 |
Price Performance
Historical ComparisonAbout ELF e.l.f. Beauty Inc.
e.l.f. Beauty Inc is a multi-brand beauty company that offers inclusive, accessible, clean, vegan, and cruelty-free cosmetics and skin care products. The Company's mission is to make beauty accessible to every eye, lip, face, and skin concern. The company offers cosmetic accessories for women, which include eyeliner, mascara, false eyelashes, lipstick, foundation for the face, moisturizer, cleanser, and other tools through its stores and e-commerce channels.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.